Showcasing the next generation of gene writing tools to cure diseases for Integra Therapeutics

The lead technology is FiCAT, a best-in-class platform geared towards resolving the current limitations on gene writing: size, precision, and stability. FiCAT combines the precision of CRISPR-Cas and the transfer efficiency of an engineered piggyBac transposase protein with the capability to deliver small and large payloads.

The Goal

"To manifest the advanced therapies in genetic and oncological diseases."

"I have really enjoyed the creative process of generating this video with the nanobot medical team; they understood our goal and were willing to accommodate our needs. In addition, it was a blast working with such a high-performance team of women in STEM and design!"